Veriti Management LLC Alkermes Plc. Transaction History
Veriti Management LLC
- $1.83 Billion
- Q3 2024
A detailed history of Veriti Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Veriti Management LLC holds 9,571 shares of ALKS stock, worth $282,057. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,571
Previous 8,491
12.72%
Holding current value
$282,057
Previous $204,000
30.88%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ALKS
# of Institutions
361Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$858 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$559 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$383 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$373 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$271 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.84B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...